Cargando…
A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction
(1) To investigate the role of azurocidin, an antimicrobial protein, in patients with ST segment elevation myocardial infarction (STEMI). (2) This single-center prospective observational study included patients with STEMI and healthy age- and sex-matched control subjects. Baseline demographic, clini...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321077/ https://www.ncbi.nlm.nih.gov/pubmed/30501029 http://dx.doi.org/10.3390/ijms19123797 |
_version_ | 1783385356175933440 |
---|---|
author | Ipek, Emrah Yolcu, Mustafa Yildirim, Erkan Altinkaynak, Konca Ozbek Sebin, Saime Kalkan, Kamuran Gulcu, Oktay Ermis, Emrah Ozturk, Mustafa |
author_facet | Ipek, Emrah Yolcu, Mustafa Yildirim, Erkan Altinkaynak, Konca Ozbek Sebin, Saime Kalkan, Kamuran Gulcu, Oktay Ermis, Emrah Ozturk, Mustafa |
author_sort | Ipek, Emrah |
collection | PubMed |
description | (1) To investigate the role of azurocidin, an antimicrobial protein, in patients with ST segment elevation myocardial infarction (STEMI). (2) This single-center prospective observational study included patients with STEMI and healthy age- and sex-matched control subjects. Baseline demographic, clinical and biochemical data were compared between the two groups. Azurocidin levels at baseline were determined using an enzyme-linked immunosorbent assay. Multivariate linear regression analysis with enter method was used to test the association between azurocidin and independent variables, such as the thrombolysis in myocardial infarction (TIMI) score, synergy between percutaneous coronary intervention with TAXUS and cardiac surgery score, global registry of acute coronary events score, Killip class, C-reactive protein (CRP), and creatinine kinase-myocardial band (CK-MB). (3) A total of 76 patients with STEMI and 30 healthy control subjects were enrolled in the study. Mean ± SD azurocidin levels were significantly higher in patients compared with healthy controls (18.07 ± 13.99 versus 10.09 ± 5.29 ng/mL, respectively). In a receiver-operating characteristic curve analysis, an azurocidin cut-off level of >11.46 ng/mL had 74% sensitivity and 58% specificity in predicting myocardial infarction. Azurocidin levels had a positive correlation with TIMI score (r = 0.651). In multivariate linear regression analysis, the TIMI score was an independent predictor of the azurocidin level. (4) Azurocidin is an infection marker that may be important in patients with STEMI. |
format | Online Article Text |
id | pubmed-6321077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63210772019-01-07 A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction Ipek, Emrah Yolcu, Mustafa Yildirim, Erkan Altinkaynak, Konca Ozbek Sebin, Saime Kalkan, Kamuran Gulcu, Oktay Ermis, Emrah Ozturk, Mustafa Int J Mol Sci Article (1) To investigate the role of azurocidin, an antimicrobial protein, in patients with ST segment elevation myocardial infarction (STEMI). (2) This single-center prospective observational study included patients with STEMI and healthy age- and sex-matched control subjects. Baseline demographic, clinical and biochemical data were compared between the two groups. Azurocidin levels at baseline were determined using an enzyme-linked immunosorbent assay. Multivariate linear regression analysis with enter method was used to test the association between azurocidin and independent variables, such as the thrombolysis in myocardial infarction (TIMI) score, synergy between percutaneous coronary intervention with TAXUS and cardiac surgery score, global registry of acute coronary events score, Killip class, C-reactive protein (CRP), and creatinine kinase-myocardial band (CK-MB). (3) A total of 76 patients with STEMI and 30 healthy control subjects were enrolled in the study. Mean ± SD azurocidin levels were significantly higher in patients compared with healthy controls (18.07 ± 13.99 versus 10.09 ± 5.29 ng/mL, respectively). In a receiver-operating characteristic curve analysis, an azurocidin cut-off level of >11.46 ng/mL had 74% sensitivity and 58% specificity in predicting myocardial infarction. Azurocidin levels had a positive correlation with TIMI score (r = 0.651). In multivariate linear regression analysis, the TIMI score was an independent predictor of the azurocidin level. (4) Azurocidin is an infection marker that may be important in patients with STEMI. MDPI 2018-11-29 /pmc/articles/PMC6321077/ /pubmed/30501029 http://dx.doi.org/10.3390/ijms19123797 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ipek, Emrah Yolcu, Mustafa Yildirim, Erkan Altinkaynak, Konca Ozbek Sebin, Saime Kalkan, Kamuran Gulcu, Oktay Ermis, Emrah Ozturk, Mustafa A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction |
title | A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction |
title_full | A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction |
title_fullStr | A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction |
title_full_unstemmed | A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction |
title_short | A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction |
title_sort | novel marker of inflammation: azurocidin in patients with st segment elevation myocardial infarction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321077/ https://www.ncbi.nlm.nih.gov/pubmed/30501029 http://dx.doi.org/10.3390/ijms19123797 |
work_keys_str_mv | AT ipekemrah anovelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT yolcumustafa anovelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT yildirimerkan anovelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT altinkaynakkonca anovelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT ozbeksebinsaime anovelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT kalkankamuran anovelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT gulcuoktay anovelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT ermisemrah anovelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT ozturkmustafa anovelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT ipekemrah novelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT yolcumustafa novelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT yildirimerkan novelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT altinkaynakkonca novelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT ozbeksebinsaime novelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT kalkankamuran novelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT gulcuoktay novelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT ermisemrah novelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction AT ozturkmustafa novelmarkerofinflammationazurocidininpatientswithstsegmentelevationmyocardialinfarction |